<SEC-DOCUMENT>0001193125-24-154380.txt : 20240604
<SEC-HEADER>0001193125-24-154380.hdr.sgml : 20240604
<ACCEPTANCE-DATETIME>20240604171602
ACCESSION NUMBER:		0001193125-24-154380
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20240531
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Termination of a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240604
DATE AS OF CHANGE:		20240604

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PLUS THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001095981
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				330827593
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34375
		FILM NUMBER:		241019407

	BUSINESS ADDRESS:	
		STREET 1:		4200 MARATHON BLVD.
		STREET 2:		SUITE 200
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78756
		BUSINESS PHONE:		737.255.7194

	MAIL ADDRESS:	
		STREET 1:		4200 MARATHON BLVD.
		STREET 2:		SUITE 200
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78756

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CYTORI THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20050712

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MACROPORE INC
		DATE OF NAME CHANGE:	20010320
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d840235d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:pstv="http://www.plustherapeutics.com/20240531" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_SecurityExchangeName" name="dei:SecurityExchangeName" contextRef="duration_2024-05-31_to_2024-05-31">NASDAQ</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-292">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2024-05-31_to_2024-05-31">0001095981</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="pstv-20240531.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-05-31_to_2024-05-31"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001095981</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-05-31</xbrli:startDate> <xbrli:endDate>2024-05-31</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:11pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:11pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="white-space:nowrap">FORM&#160;<ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-303">8-K</ix:nonNumeric></span></p> <p style="font-size:11pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:11pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:11pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported):&#160;<ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-05-31_to_2024-05-31" format="ixt:datemonthdayyearen" id="ixv-304">May 31, 2024</ix:nonNumeric></p> <p style="font-size:11pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:11pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-305">PLUS THERAPEUTICS, INC.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:11pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:11pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-05-31_to_2024-05-31" format="ixt-sec:stateprovnameen" id="ixv-306">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-307">001-34375</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-308">33-0827593</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="margin-top:11pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-309">4200 Marathon Blvd.</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-310">Suite 200</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-311">Austin</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-05-31_to_2024-05-31" format="ixt-sec:stateprovnameen" id="ixv-312">Texas</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-313">78756</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of principal executive offices) (Zip Code)</p> <p style="margin-top:11pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code:&#160;<ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-314">(737)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-315">255-7194</ix:nonNumeric></span></p> <p style="font-size:11pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:11pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-05-31_to_2024-05-31" format="ixt-sec:boolballotbox" id="ixv-316">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-05-31_to_2024-05-31" format="ixt-sec:boolballotbox" id="ixv-317">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-05-31_to_2024-05-31" format="ixt-sec:boolballotbox" id="ixv-318">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-05-31_to_2024-05-31" format="ixt-sec:boolballotbox" id="ixv-319">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:11pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:11pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-320">Common Stock, $0.001 par value per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-321">PSTV</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <span style=" -sec-ix-hidden:Hidden_dei_SecurityExchangeName">The Nasdaq Capital Market</span> </td></tr></table> <p style="margin-top:11pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="font-size:11pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-05-31_to_2024-05-31" format="ixt-sec:boolballotbox" id="ixv-322">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Emerging Growth Company</p></td></tr></table> <p style="margin-top:11pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;1.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On May&#160;31, 2024, Plus Therapeutics, Inc. (the &#8220;Company&#8221;) drew $3.3&#160;million on its existing margin loan facility (the &#8220;Pershing Credit Facility&#8221;) with Pershing LLC (&#8220;Pershing&#8221;), an affiliate of The Bank of New York Mellon Corporation. The Company drew the funds to make the repayments described under Item 1.02 below. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Borrowings under the Pershing Credit Facility bear interest at the target interest rate set by the Federal Open Market Committee, subject to a floor of 5.5%, plus a spread of 1.75% and applicable fees of 0.5%, subject to a maximum interest rate of the then applicable Prime Rate as published in The Wall Street Journal plus 3.0%. Interest payments thereunder are calculated on a monthly basis and, unless paid, are added to the outstanding balance under the Pershing Credit Facility. The proceeds under the Pershing Credit Facility are available for working capital needs and other general corporate purposes. The Pershing Credit Facility includes certain covenants and restrictions, which may require the Company, on an <span style="white-space:nowrap">on-going</span> basis, to deposit additional funds or marketable securities in order to maintain the line of credit extended by Pershing. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The available credit line limit under the Pershing Credit Facility fluctuates based on the Company&#8217;s request for extensions of credit from time to time, subject to the value of the collateralized marketable securities that the Company holds with Pershing, provided that the amount available to draw under the Pershing Credit Facility cannot exceed 91.5% of the value of the Company&#8217;s collateralized marketable securities deposited with Pershing (the &#8220;Collateral&#8221;). Depending on the value of the Collateral that the Company holds with Pershing, Pershing may require the Company, on an <span style="white-space:nowrap">on-going</span> basis, to deposit additional funds or marketable securities in order to restore the level of the Collateral to an acceptable level. The amounts borrowed under the Pershing Credit Facility are due on demand. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Pershing Credit Facility is secured by a general lien and security interest in the Company&#8217;s Collateral held in its account with Pershing. Upon certain customary events of default, Pershing has the right, in its discretion, to liquidate, withdraw or sell all or any part of the Collateral and apply the proceeds to the amounts outstanding under the Pershing Credit Facility. The Pershing Credit Facility is also subject to certain customary terms and conditions. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of the Pershing Credit Facility does not purport to be complete and is qualified in its entirety by reference to the full and complete terms of the Pershing Credit Facility loan documents, copies of which are filed hereby as Exhibits 10.1, 10.2 and 10.3 and are incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;1.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Termination of a Material Definitive Agreement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On May&#160;29, 2015, the Company entered into a Loan and Security Agreement, that was subsequently amended, with Oxford Finance, LLC (&#8220;Oxford&#8221;) (the &#8220;Oxford Term Loan&#8221;). On June&#160;3, 2024, following the drawing of $3.3&#160;million on the Pershing Credit Facility on May&#160;31, 2024, the Company repaid the Oxford Term Loan in full, a payment amount that totaled approximately $3.3&#160;million, which included both the balance of outstanding principal and interest and the final payment fee due. The repayment in full of the Oxford Term Loan terminated Oxford&#8217;s security interest in the Company&#8217;s existing and after-acquired assets, as well as all other certain restrictions and covenants under the Oxford Term Loan. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;2.03</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Creation of a Direct Financial Obligation or an Obligation under an <span style="white-space:nowrap">Off-Balance</span> Sheet Arrangement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information set forth in Item 1.01 of this Current Report on Form <span style="white-space:nowrap">8-K</span> is incorporated in this Item 2.03 by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d840235dex101.htm">Lending Agreement, dated April&#160;5, 2024, by and between Plus Therapeutics, Inc. and Pershing LLC </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d840235dex102.htm">Loan Interest Rate Form, dated May&#160;24, 2024, by and between Plus Therapeutics, Inc. and Pershing LLC </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d840235dex103.htm">Extension of Credit, dated May&#160;29, 2024, by and between Plus Therapeutics, Inc. and Pershing LLC </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:44%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:5%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:44%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">PLUS THERAPEUTICS, INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: June&#160;4, 2024</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Andrew Sims</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Andrew Sims</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Chief Financial Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d840235dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:3%; font-size:28pt; font-family:ARIAL"><FONT COLOR="#636466">LoanAdvance<SUP STYLE="font-size:75%; vertical-align:top">TM</SUP> Lending Agreement </FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #636466">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<DIV STYLE="position:relative;float:left; width:0%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:93%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:1pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify"><B>KEEP A COPY FOR YOUR RECORDS.</B> This is your LoanAdvance Lending Agreement with Pershing LLC
(&#147;<U>Pershing</U>&#148;). </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>TO: Pershing LLC </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">In consideration of your accepting and carrying for the undersigned one or more accounts introduced to you by my broker, bank, or other introducing firm
(&#147;<U>Introducing Firm</U>&#148;), which Introducing Firm is intended to have the benefit and is a third party beneficiary of this agreement, the undersigned agrees as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>Role of Pershing </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">I understand that Pershing
is the carrier of the accounts of the undersigned as clearing broker pursuant to a clearing agreement with the Introducing Firm. Until receipt from the undersigned of written notice to the contrary, Pershing may accept from the Introducing Firm,
without inquiry or investigation, instructions concerning said accounts. Notices to the undersigned concerning LoanAdvance loan requirements or other matters related to the undersigned&#146;s accounts usually will go through the undersigned&#146;s
Introducing Firm although direct notice to the undersigned with duplicate notice to the undersigned&#146;s Introducing Firm may occur if market conditions, time constraints, or other circumstances require it. Pershing shall not be responsible or
liable for any acts or omissions of the Introducing Firm or its employees. I understand that Pershing provides no investment advice, nor does Pershing give advice or offer any opinion with respect to the suitability of any transaction or order. I
understand that my Introducing Firm is not acting as the agent of Pershing and I agree that I will in no way hold Pershing, its other divisions, and its officers, directors, agents, or affiliates liable for any trading losses incurred by me. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>1. Applicable Rules and Regulations </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">All
transactions for the undersigned shall be subject to the constitution, rules, regulations, customs, and usages of the exchange or market and its clearing house, if any, where executed by Pershing or its agents, including its subsidiaries and
affiliates. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>2. Definitions </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">For purposes
of this agreement &#147;<U>securities, commodities, and other property</U>,&#148; as used herein shall include, but not be limited to money, securities, and commodities of every kind and nature and all contracts and options relating thereto, whether
for present or future delivery. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>3. Lien </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">All securities, commodities, and other property of the undersigned, which Pershing may at any time be carrying for the undersigned, or which may at any
time be in Pershing&#146;s possession or under Pershing&#146;s control, shall be subject to a general lien and security interest in Pershing&#146;s favor for the discharge of all of the undersigned&#146;s indebtedness and other obligations to
Pershing, without regard to Pershing having made any advances in connection with such securities and other property and without regard to the number of accounts the undersigned may have with Pershing. In enforcing its lien, Pershing shall have the
discretion to determine which securities and property are to be sold and which contracts are to be closed. Securities and other property held in the undersigned&#146;s retirement account(s) maintained by Pershing, which may include IRAs or qualified
plans, are not subject to this general lien and such securities or other property may only be used to satisfy the undersigned&#146;s indebtedness or other obligations to your Introducing Firm and/or Pershing related to the undersigned&#146;s
retirement account(s). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>4. Liquidation </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">If, in its discretion, Pershing considers it necessary for its protection to require additional collateral, or in the event that a petition in
bankruptcy is filed, or an appointment of a receiver is filed by or against the undersigned, or an attachment is levied against the accounts of the undersigned, or in the event of the death of the undersigned, Pershing shall have the right to
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">sell any or all securities, commodities, and other property in the accounts of the undersigned with
Pershing, whether carried individually or jointly with others, to buy any or all securities, commodities, and other property which may be short in such accounts, to cancel any open orders, and to close any or all outstanding contracts, all without
demand for collateral or additional collateral, notice of sale or purchase, or other notice or advertisement. Any such sales or purchases may be made at Pershing&#146;s discretion on any exchange or other market where such business is usually
transacted, or at public auction or private sale, and Pershing may be the purchaser for its own account. It being understood that a prior demand, or call, or prior notice of the time and place of such sale or purchase shall not be considered a
waiver of Pershing&#146;s right to sell or buy without demand or notice. To the extent permitted by law, the undersigned waive compliance with the provisions of Section&nbsp;202 of the New York Lien Law, including notice of sale, advertisement and
related provisions of Article 9 of the New York Lien Law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>5. Payment of Indebtedness Upon Demand and Liability for Costs of Collection </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">The undersigned shall at all times be liable for the payment upon demand of any debit balance or other obligations owing in any of the accounts of the
undersigned with Pershing, and the undersigned shall be liable to Pershing for any deficiency remaining in any such accounts in the event of the liquidation thereof, in whole or in part, by Pershing or by the undersigned; and, the undersigned shall
make payments of such obligations and indebtedness upon demand. The reasonable cost and expense of collection of the debit balance, recovery of securities, and any unpaid deficiency in the accounts of the undersigned with Pershing, including, but
not limited to attorney&#146;s fees, incurred and payable or paid by Pershing, shall be payable to Pershing by the undersigned. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>6. Pledge of
Securities </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">All securities, commodities, and other property now or hereafter held, carried, or maintained by Pershing in its possession in any
of the accounts of the undersigned may be pledged, repledged, hypothecated or rehypothecated by Pershing from time to time, without notice to the undersigned, either separately or in common with other such securities, commodities, and other property
for any amount due in the accounts of the undersigned, or for any greater amount, and Pershing may do so without retaining into its possession or control for delivery, a like amount of similar securities, commodities, or other property. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>7. Credit Charges </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">The monthly debit balances
or adjusted balances in the accounts of the undersigned with Pershing shall be charged, in accordance with its practice, with interest at a rate permitted by the laws of the State of New York, as further described in this agreement. It is understood
that the interest charge made to the undersigned&#146;s account at the close of a charge period will be added to the opening balance for the next charge period unless paid. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>8. LoanAdvance Account </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">LoanAdvance enables
the undersigned to obtain a loan secured by the securities, commodities, and other property now or hereafter held, carried, or maintained by the undersigned in Pershing&#146;s possession. Any such loan will be made in a special LoanAdvance account
that is not a margin account. Pershing will establish in the LoanAdvance account, on behalf of the undersigned, a line of credit through which the undersigned may obtain the loan. Each loan disbursement will appear as a debit balance on the monthly
or quarterly statement of the account. The undersigned agrees that Pershing will charge interest on the debit balance and that Pershing will require the undersigned to maintain securities, cash, or
</P></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:1%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">
</P></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="93%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">

<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL" ALIGN="justify">&copy;&nbsp;2021 Pershing LLC. Pershing LLC, member FINRA, NYSE, SIPC, is a wholly owned subsidiary of</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:ARIAL" ALIGN="justify">The Bank of New York Mellon Corporation (BNY Mellon). Trademark(s) belong to their respective owners.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">PAGE 1 OF 6</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="right">ECAGR-LA-08-21</P></TD></TR></TABLE> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center">FORM GENERATED
ON:04/05/2024 - 11:15AM EDT </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3%; font-size:15pt; font-family:ARIAL"><FONT COLOR="#636466">LoanAdvance<SUP STYLE="font-size:75%; vertical-align:top">TM</SUP> Lending
Agreement </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #636466">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<DIV STYLE="position:relative;float:left; width:0%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:93%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
<DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">other property to secure repayment of funds advanced and interest due in accordance with procedures
herein. The loan may be obtained by any one of the undersigned with the understanding that all of the undersigned will be liable, jointly and severally, for repayment of the loan and interest thereon. The loan may be obtained up to a credit limit
that Pershing will establish. The credit limit may fluctuate from time to time, based on the value of the collateral held in the brokerage or managed account(s) being used as collateral and Pershing&#146;s current collateral requirements. In
addition, interest and fees assessed to the LoanAdvance account are considered an extension of the loan and are taken into account when determining the available credit limit. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>9. Limitations of LoanAdvance </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">LoanAdvance
loans may be used for any lawful purpose other than to purchase, carry, or trade securities, to meet margin calls relating to securities purchases, or for reducing or retiring indebtedness incurred to purchase, carry, or trade securities. The client
is permitted frequent asset substitutions, provided that the equity and collateral remains at an acceptable level. Note: Mutual fund purchases and sales must be within the same family of funds in order to get immediate release on collateral. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">NOTE: In addition, when the collateral and loan are held within the same brokerage account, only occasional collateral substitutions that occur on the
same day are permitted, and transactions cannot increase the client&#146;s loan balance. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>10. Interest Rates </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">Your Base Rate, as defined in the interest rate disclosure, will change without prior notice. When your Base Rate changes during an interest period,
interest will be calculated according to the number of days each rate is in effect during that period. Regardless of the underlying Base Rate, interest charged in any credit extended in a LoanAdvance account may never exceed a rate equal to 3
percentage points above the Prime Rate as published in The Wall Street Journal. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>11. Interest Period </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">The interest period begins on the 20th of each month and ends on the 19th of the following month. Accordingly, the interest charges for the period as
shown on the monthly or quarterly statement are based only on the daily net debit balances for the interest period. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>12. Method of Interest
Computation </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">At the close of each interest period during which credit was extended in a LoanAdvance account, an interest charge is computed by
multiplying the average daily debit balance by the applicable schedule rate, and then by the number of days during which a debit balance was outstanding, and finally dividing by 360. If there has been a change in the Base Rate, separate computations
will be made with respect to each rate of charge for the appropriate number of days at each rate during the interest period. The interest charge for credit made to a LoanAdvance account at the close of the interest period is added to the opening
debit balance for the next interest period unless paid. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>13. General Collateral Policies </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">The amount of credit that may be extended (the credit limit) by Pershing will be set from time to time. If the market value of securities in a brokerage
or managed account(s) being used as collateral declines, Pershing may require the deposit of additional collateral. The equity in a brokerage or managed account(s) being used as collateral is the current market value of securities and cash deposited
as security less the amount owed to Pershing for credit extended. For information with respect to general collateral maintenance policy as to stocks, municipal bonds, corporate bonds, listed U.S. Treasury notes and bonds, mutual funds, and other
securities, as well as information about the eligibility of particular securities for LoanAdvance purposes, the undersigned should contact the Introducing Firm. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">Pershing reserves the right, at its discretion, to require the deposit of additional collateral and to set collateral requirements at a higher or lower
amount with respect to particular accounts or classes of accounts, as Pershing deems necessary. In making this determination, Pershing may take into account various factors including but not limited to
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">
(i) issues as to the undersigned&#146;s securities such as, among others, the liquidity of a position and concentrations of securities in an account, </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">(ii)&nbsp;considerations as to the undersigned&#146;s status, including but not limited to a decline in creditworthiness, (iii)&nbsp;the size of the
account, (iv)&nbsp;the general condition of the market, (v)&nbsp;considerations as to the ability of Pershing to obtain financing, and (vi)&nbsp;regulatory interpretations or guidance. If the undersigned fails to meet a call for additional
collateral in a timely manner, some or all of the positions held by the undersigned may be liquidated. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>14. Deposits of Collateral, Lien on
Accounts, and Liquidation </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">In the event that additional collateral is requested due to a downturn in the market and/or the decline in value of
your securities held as collateral, the undersigned may be required to deposit funds or acceptable securities into the brokerage or managed account(s) in order to restore the level of collateral to an acceptable level. If satisfactory collateral is
not promptly deposited after a request is made, Pershing may, at its discretion, liquidate securities held in any of the undersigned accounts. If securities are liquidated based on the need for additional collateral, the undersigned understands that
there may be tax implications associated with the liquidation, such as capital gains tax, depending on your cost basis in the collateral and other factors affecting your tax status. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>15. Credit Investigation, Negative Credit Report </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">The undersigned authorizes Pershing to exchange credit information about the undersigned and the account with others. As required by law, the
undersigned is notified that any negative credit report that appears on his or her credit records may be submitted to a credit reporting agency if the undersigned fails to fulfill the terms of the credit obligations. Pershing may request a credit
report on the undersigned. Upon request by the undersigned, Pershing will state the name and address of the consumer reporting agency that furnished it. If Pershing extends, updates, reviews, or renews credit to the undersigned, Pershing may request
a new credit report without notifying the undersigned. Pershing may also request a new credit report in accordance with its normal account maintenance procedures without notifying the undersigned. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>16. Communications </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">Communications may be sent
to the undersigned at the current address of the undersigned, which is on file at Pershing&#146;s office, or at such other address as the undersigned may hereafter give Pershing in writing, or through the Introducing Firm, and all communications, so
sent, whether by mail, telegraph, messenger, or otherwise, shall be deemed given to the undersigned personally, whether actually received or not. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>17. Scope and Transferability </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">This agreement
shall cover individually and collectively all accounts that the undersigned may open or reopen with Pershing for the purpose of obtaining a LoanAdvanceloan , and shall inure to the benefit of its successors and assigns, whether by merger,
consolidation, or otherwise, and Pershing may transfer the accounts of the undersigned to its successors and assigns, and this agreement shall be binding upon the heirs, executors, administrators, successors, and assigns of the undersigned. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>18. No Professional Advice </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">The undersigned
acknowledges that Pershing will not provide the undersigned with any investment, legal, tax, or accounting advice, that its employees are not authorized to give any such advice, and that the undersigned will not solicit or rely upon any such advice
from Pershing or its employees whether in connection with transactions in or for any of the accounts of the undersigned or otherwise. In making investment, legal, tax, or accounting decisions with respect to transactions in or for the accounts of
the undersigned or any other matter, the undersigned will consult with and rely upon its own advisors and not Pershing, and Pershing shall have no liability therefore. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>19. Deduction or Withholding for Tax </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">All
payments under this agreement shall be made without any deduction or withholding for any taxes imposed by any laws, regulations, decrees, or ordinances other than U.S. state or federal laws (&#147;Local Taxes&#148;). The
</P></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:1%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">
</P></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="93%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">

<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL" ALIGN="justify">&copy;&nbsp;2021 Pershing LLC. Pershing LLC, member FINRA, NYSE, SIPC, is a wholly owned subsidiary of</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:ARIAL" ALIGN="justify">The Bank of New York Mellon Corporation (BNY Mellon). Trademark(s) belong to their respective owners.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">PAGE 2 OF 6</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="right">ECAGR-LA-08-21</P></TD></TR></TABLE> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center">FORM GENERATED
ON:04/05/2024 - 11:15AM EDT </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3%; font-size:15pt; font-family:ARIAL"><FONT COLOR="#636466">LoanAdvance<SUP STYLE="font-size:75%; vertical-align:top">TM</SUP> Lending
Agreement </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #636466">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<DIV STYLE="position:relative;float:left; width:0%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:93%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
<DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">undersigned shall indemnify and hold Pershing harmless against any Local Taxes (including interest and
penalties) levied or imposed upon Pershing (directly or by way of withholding taxes) in respect of any payment under this Agreement. The undersigned shall, upon being notified that any Local Taxes, interest, and/or penalties are owed, promptly pay
to the relevant authorities the full amount required to be paid, deducted, or withheld, and cooperate fully with Pershing to the extent that any additional action or documentation is requested by Pershing or otherwise required. </P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">The undersigned agrees that any payments and/or interest that may be owed to Pershing, shall be made net payment of any Local Taxes, interest or penalties
that may be owed by the undersigned pursuant to this Agreement. </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify"><B>20. Extraordinary Events </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">Pershing shall not be liable for loss caused directly or indirectly by government restrictions, exchange or market rulings, suspension of trading, war,
strikes, or other conditions beyond its control. </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify"><B>21. Recording Conversations </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">The undersigned acknowledges, understands, and agrees that for our mutual protection, Pershing may electronically record any telephone conversation
between any of the undersigned and Pershing. </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify"><B>22. Representations as to Capacity to Enter Into Agreement </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">The undersigned, if an individual, represents that he or she is of full age, that unless otherwise disclosed to Pershing in writing the undersigned is not
an employee of any exchange; or an employee of any corporation of which any exchange owns a majority of the capital stock; or an employee of a member firm or member corporation registered on any exchange; or an employee of a bank, trust company, or
insurance company; or an employee of any corporation, firm, or individual engaged in the business of dealing either as a broker or as principal in securities, bills of exchange, acceptances, or other forms of commercial paper. The undersigned
further represents that no one except the undersigned has an interest in the account or accounts of the undersigned with Pershing. </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify"><B>23. Joint and
Several Liability </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">If the undersigned shall consist of more than one individual, their obligations under this agreement shall be joint and
several. The undersigned have executed the Joint Account Agreement and made the election required therein. Pursuant to that agreement, Pershing may, but is not required to, accept instructions from either joint party. </P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify"><B>24. Option Transactions </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">If at any time the
undersigned shall enter into any transaction for the purchase or resale of an option contract, the undersigned hereby agrees to abide by the rules of any national securities association, registered securities exchange, or clearing organization
applicable to the trading of option contracts and, acting alone or in concert, will not violate the position or exercise limitation rules of any such association or exchange or of the Options Clearing Corporation or other clearing organization. </P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify"><B>25. Severability </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">If any provision or
condition of this agreement shall be held to be invalid or unenforceable by any court, or regulatory or self-regulatory agency or body, such invalidity or unenforceability shall attach only to such provision or condition. The validity of the
remaining provisions and conditions shall not be affected thereby and this agreement shall be carried out as if any such invalid or unenforceable provision or condition were not contained herein. </P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify"><B>26. Callable Securities </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">Securities which are
held for the account of the undersigned and which are in &#147;street name,&#148; or are being held by a securities depository, are commingled with the same securities being held for other clients of introducing firms and for Pershing&#146;s own
customers. The ownership of these securities by the undersigned is reflected in Pershing&#146;s records. The undersigned has the right at any time to require delivery of any such securities that are fully paid for, or are in excess of, collateral
requirements. </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">The terms of many bonds allow the issuer to partially redeem or &#147;call&#148; the issue prior to maturity date. Certain preferred
stocks are also subject
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">
to being called by the issuer. Whenever any such security being held by Pershing is partially &#147;called,&#148; Pershing will determine through a random selection procedure as prescribed by the
New York Stock Exchange rules, the ownership of the securities to be submitted for redemption. In the event that such securities owned by the undersigned are selected and redeemed, the accounts of the undersigned will be credited with the proceeds.
</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">In order not to be subject to this random selection process, the undersigned must instruct the Introducing Firm to have Pershing deliver the
securities to the undersigned. Delivery will be effected provided, of course, that the position is unencumbered or had not already been called by the issuer as described, prior to receipt by Pershing of the instructions of the undersigned. The
probability of a security being called is the same whether they are held by Pershing or by the undersigned. </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify"><B>27. Lost Securities </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">If a periodic client account statement indicates that securities were forwarded to the undersigned and the undersigned does not receive them, notify your
Introducing Firm or Pershing immediately. If notification is received within 120 days after the mailing date of the securities, as reflected on the periodic statement, replacement will be made free of charge. Thereafter, a fee for replacement may
apply. </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify"><B>28. Headings Are Descriptive </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">The
heading of each provision hereof is for descriptive purposes only and shall not be deemed to modify or qualify any of the rights or obligations set forth in each such provision. </P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify"><B>29. Assignment of Pershing&#146;s Rights Under This Agreement to the Introducing Firm </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">The undersigned agrees that any rights that Pershing has under this agreement, including but not limited to the right to collect any debit balance or
other obligations owing in any of the accounts of the undersigned, may be assigned without the undersigned&#146;s consent or notice to the Introducing Firm of the undersigned so that the undersigned&#146;s Introducing Firm may collect from the
undersigned independently or jointly with Pershing or enforce any other rights granted to Pershing under this agreement. </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify"><B>30. Amendments </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">Pershing may amend this agreement from time to time by sending a notice of such amendment to one of the undersigned. </P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify"><B>31. No Waiver </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">This agreement cannot be
modified by conduct and no failure on the part of Pershing at any time to enforce its rights hereunder to the greatest extent permitted shall in any way be deemed to waive, modify, or relax all of the rights granted Pershing herein, including those
rights vested in Pershing to deal with collateral on all loans advanced to me. </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify"><B>32. Indemnification </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">Without the necessity of a judicial determination, and whether or not litigation occurs, the undersigned agree to indemnify and hold harmless Pershing,
undersigned&#146;s Introducing Firm and their respective directors, officers, employees, agents and affiliates from any and all claims (whether or not meritorious), liabilities, judgments, damages, losses, costs and expenses of any nature whatsoever
(including reasonable attorney&#146;s fees and expenses) in any way related to, or arising out of or in connection with, this agreement, including without limitation, the grant by the undersigned of a first priority lien and security interest in the
collateral held in the brokerage or managed account(s) and any action taken or omitted by Pershing or the undersigned&#146;s Introducing Firm at the request of the undersigned or pursuant to instructions provided by the undersigned. </P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify"><B>33. Entire Agreement </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">This agreement
constitutes the full and entire understanding between the parties with respect to the provisions herein, and there are no oral or other agreements in conflict herewith. Any future modification, amendment, or supplement to this agreement or any
individual provision herein can only be in the form of a writing signed by a representative of Pershing. </P></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:1%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">
</P></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="93%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">

<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL" ALIGN="justify">&copy;&nbsp;2021 Pershing LLC. Pershing LLC, member FINRA, NYSE, SIPC, is a wholly owned subsidiary of</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:ARIAL" ALIGN="justify">The Bank of New York Mellon Corporation (BNY Mellon). Trademark(s) belong to their respective owners.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">PAGE 3 OF 6</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="right">ECAGR-LA-08-21</P></TD></TR></TABLE> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center">FORM GENERATED
ON:04/05/2024 - 11:15AM EDT </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3%; font-size:15pt; font-family:ARIAL"><FONT COLOR="#636466">LoanAdvance<SUP STYLE="font-size:75%; vertical-align:top">TM</SUP> Lending
Agreement </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #636466">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<DIV STYLE="position:relative;float:left; width:0%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:93%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
<DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify"><B>34. Arbitration Disclosures </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify"><B>THIS AGREEMENT CONTAINS A PREDISPUTE ARBITRATION CLAUSE. BY SIGNING AN ARBITRATION AGREEMENT THE PARTIES AGREE AS FOLLOWS: </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:8pt"><B>ALL PARTIES TO THIS AGREEMENT ARE GIVING UP THE RIGHT TO SUE EACH OTHER IN COURT, INCLUDING THE RIGHT TO A TRIAL BY
JURY, EXCEPT AS PROVIDED BY THE RULES OF THE ARBITRATION FORUM IN WHICH A CLAIM IS FILED. </B></P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:8pt"><B>ARBITRATION AWARDS ARE GENERALLY FINAL AND BINDING; A PARTY&#146;S ABILITY TO HAVE A COURT REVERSE OR MODIFY AN
ARBITRATION AWARD IS VERY LIMITED. </B></P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:8pt"><B>THE ABILITY OF THE PARTIES TO OBTAIN DOCUMENTS, WITNESS STATEMENTS AND OTHER DISCOVERY IS GENERALLY MORE LIMITED IN
ARBITRATION THAN IN COURT PROCEEDINGS. </B></P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:8pt"><B>THE ARBITRATORS DO NOT HAVE TO EXPLAIN THE REASON(S) FOR THEIR AWARD, UNLESS, IN AN ELIGIBLE CASE, A JOINT REQUEST FOR
AN EXPLAINED DECISION HAS BEEN SUBMITTED BY ALL PARTIES TO THE PANEL AT LEAST 20 DAYS PRIOR TO THE FIRST SCHEDULED HEARING DATE. </B></P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:8pt"><B>THE PANEL OF ARBITRATORS WILL TYPICALLY INCLUDE A MINORITY OF ARBITRATORS WHO WERE OR ARE AFFILIATED WITH THE
SECURITIES INDUSTRY. </B></P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:8pt"><B>THE RULES OF SOME ARBITRATION FORUMS MAY IMPOSE TIME LIMITS FOR BRINGING A CLAIM IN ARBITRATION. IN SOME CASES, A
CLAIM THAT IS INELIGIBLE FOR ARBITRATION MAY BE BROUGHT IN COURT. </B></P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:8pt"><B>THE RULES OF THE ARBITRATION FORUM IN WHICH THE CLAIM IS FILED, AND ANY AMENDMENTS THERETO, SHALL BE INCORPORATED INTO
THIS AGREEMENT. </B></P></TD></TR></TABLE> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify"><B>35. Arbitration Agreement </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify"><B>ANY CONTROVERSY BETWEEN YOU AND US SHALL BE SUBMITTED TO ARBITRATION BEFORE AND ONLY BEFORE THE FINANCIAL INDUSTRY REGULATORY AUTHORITY. </B></P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify"><B>NO PERSON SHALL BRING A PUTATIVE OR CERTIFIED CLASS ACTION TO ARBITRATION, NOR SEEK TO ENFORCE ANY PREDISPUTE ARBITRATION AGREEMENT AGAINST ANY PERSON
WHO HAS INITIATED IN COURT A PUTATIVE CLASS ACTION; OR WHO IS A MEMBER OF A PUTATIVE CLASS WHO HAS NOT OPTED OUT OF THE CLASS WITH RESPECT TO ANY CLAIMS ENCOMPASSED BY THE PUTATIVE CLASS ACTION UNTIL; (I)&nbsp;THE CLASS CERTIFICATION IS DENIED;
(II)&nbsp;THE CLASS IS DECERTIFIED; OR (III)&nbsp;THE CUSTOMER IS EXCLUDED FROM THE CLASS BY THE COURT. SUCH FORBEARANCE TO ENFORCE AN AGREEMENT TO ARBITRATE SHALL NOT CONSTITUTE A WAIVER OF ANY RIGHTS UNDER THIS AGREEMENT EXCEPT TO THE EXTENT
STATED HEREIN. </B></P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify"><B>36. The Laws of the State of New York Govern </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">This agreement and its enforcement shall be governed by the laws of the state of New York without giving effect to its conflicts of laws provisions.
</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify"><B>37. Loan Consent and Voting Rights </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">By
signing this agreement, the undersigned acknowledges that securities held in a brokerage or managed account(s) being used as collateral may be loaned to Pershing or loaned out to others and as permitted by law, certain securities in the
undersigned&#146;s account may be used for, among other things, settling short sales and lending the securities for short sales, and as a result, Pershing and the undersigned&#146;s Introducing Firm may receive compensation in connection therewith.
In the event the undersigned&#146;s securities have been loaned by Pershing on the record date of a shareholder vote involving those securities, the undersigned agrees that the undersigned&#146;s vote may be reduced to reflect the total amount of
the undersigned&#146;s securities loaned by Pershing. </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify"><B>38. Other Disclosures </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">Consumer Purposes Disclosure: Oral agreements or commitments to loan money, extend credit or to forbear from enforcing repayment of a
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">
debt including promises to extend or renew such debt are not enforceable, regardless of the legal theory upon which it is based that is in any way related to the credit agreement. To protect you
(borrower[s]) and us (creditor) from misunderstanding or disappointment, any agreements we reach covering such matters are contained in this writing, which is the complete and exclusive statement of the agreement between us, except as we may later
agree in writing to modify it. </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify"><B>LoanAdvance Disclosure Statement </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">The LoanAdvance Disclosure Statement is intended to provide some basic facts about LoanAdvance accounts and to alert you to the risks involved. Before
opening a LoanAdvance account, it is important to carefully review the Lending Agreement, Form T&#150;4, Control Stock Disclosure and LoanAdvance Interest Rate Form, and the LoanAdvance Checkwriting Application (if applicable) provided by your
financial organization or its clearing firm, Pershing LLC (&#147;<U>Pershing</U>&#148;), and to consult with your financial organization regarding any questions or concerns you may have regarding LoanAdvance accounts. </P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">If you choose to borrow funds from your financial organization or Pershing, you will need to open a LoanAdvance account. The securities held in your
brokerage or managed account(s) are used as collateral for the loan that was made to you. If the securities in your brokerage or managed account(s) being used as collateral decline in value, so does the value of the collateral supporting your loan.
As a result, your financial organization or Pershing can take action. For instance, your financial organization or Pershing can issue a call and/or sell securities or liquidate other assets in any of your brokerage accounts held with your financial
organization or Pershing in order to maintain the required equity in the collateral account(s). </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">It is important that you fully understand the risks
involved in utilizing a LoanAdvance <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">line-of-credit.</FONT></FONT> These risks include the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify"><I>Your financial organization or Pershing can force the sale of securities or other assets in your account(s). </I></P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">If the equity in your brokerage or managed account(s) being used as collateral falls below the maintenance requirements or your financial
organization&#146;s higher &#147;house&#148; requirements, your financial organization or Pershing can sell the securities or other assets in any of your accounts held at your financial organization to cover the deficiency. You also will be
responsible for any short fall in the account after such a sale. </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify"><I>Your financial organization or Pershing can sell your securities or other
assets without contacting you. </I></P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">Some investors mistakenly believe that a financial organization must contact them for a call to be valid, and that
the financial organization cannot liquidate securities or other assets in their accounts to meet the call unless the financial organization has contacted them first. This is not the case. Most financial organizations will attempt to notify their
clients of calls, but they are not required to do so. However, even if a financial organization has contacted a client and provided a specific date by which the client can meet a call, the financial organization can still take necessary steps to
protect its financial interests, including immediately selling the securities without notice to the client. </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify"><I>Your financial organization or
Pershing may change LoanAdvance requirements or account maintenance call time periods without notice to you. </I></P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="justify">In regard to house, maintenance, and
other account calls, in lieu of immediate liquidations, Pershing, through your financial organization, may permit you a period of time to satisfy a call. This time period shall not in any way waive or diminish Pershing&#146;s right in its sole
discretion, to shorten the time period in which you may satisfy a call, including one already outstanding, or to demand that a call be satisfied immediately. Nor does such practice waive or diminish the right of Pershing and/or your financial
organization to sell out positions to satisfy the call, which can be as high as the full indebtedness owed by you. LoanAdvance requirements may be established and changed by Pershing or your financial organization in its sole discretion and
judgement. </P></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:1%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">
</P></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="93%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">

<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL" ALIGN="justify">&copy;&nbsp;2021 Pershing LLC. Pershing LLC, member FINRA, NYSE, SIPC, is a wholly owned subsidiary of</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:ARIAL" ALIGN="justify">The Bank of New York Mellon Corporation (BNY Mellon). Trademark(s) belong to their respective owners.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">PAGE 4 OF 6</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="right">ECAGR-LA-08-21</P></TD></TR></TABLE> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center">FORM GENERATED
ON:04/05/2024 - 11:15AM EDT </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3%; font-size:15pt; font-family:ARIAL"><FONT COLOR="#636466">LoanAdvance<SUP STYLE="font-size:75%; vertical-align:top">TM</SUP> Lending
Agreement </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #636466">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<DIV STYLE="position:relative;float:left; width:0%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:93%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
<DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><I>You are not entitled to choose which securities or other assets in your brokerage or managed account(s)
are liquidated or sold to meet a call. </I></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">Because the securities are collateral for the LoanAdvance <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">line-of-credit,</FONT></FONT> your financial organization or Pershing has the right to decide which security to sell in order to protect its interests. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>Your financial organization or Pershing can increase its &#147;house&#148; maintenance requirements at any time and is not required to provide you with
advance written notice. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">These changes in firm policy often take effect immediately and may result in the issuance of a maintenance call. Your
failure to satisfy the call may cause your financial organization or Pershing to liquidate or sell securities in your brokerage or managed account(s). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>You are not entitled to an extension of time on a call. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">While an extension of time to meet call requirements may be available to clients under certain conditions, a client does not have a right to the
extension. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>You will be charged interest based on the Base Rate. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">The Base Rate, as defined in the LoanAdvance Interest Rate Form, will change without prior notice. When the Base Rate changes during an interest period,
interest will be calculated according to the number of days each rate is in effect during that period. Regardless of the underlying Base Rate, interest charged in any credit extended in a LoanAdvance account may never exceed a rate equal to 3
percentage points above the Prime Rate as published in The Wall Street Journal. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><I>Your interest period begins on the 20th of each month and ends on
the 19th of the following month. </I></P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">The interest charges for the period as shown on the monthly or quarterly statement are based only on the daily
net debit balances for the interest period. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><I>Your monthly interest charge will be calculated according to the following computation: </I></P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">At the close of each interest period during which credit was extended in a LoanAdvance account, an interest charge is computed by multiplying the
average daily debit balance by the applicable schedule rate, and then by the number of days during which a debit balance was outstanding,
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">
and finally dividing by 360. If there has been a change in the Base Rate, separate computations will be made with respect to each rate of charge for the appropriate number of days at each rate
during the interest period. The interest charge for credit made to a LoanAdvance account at the close of the interest period is added to the opening debit balance for the next interest period unless paid. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><I>Your written LoanAdvance Agreement with Pershing or your financial organization provides for certain important obligations by you. </I></P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">The LoanAdvance Agreement is a legally binding agreement, cannot be modified by conduct, and no failure on the part of Pershing or your financial
organization at any time to enforce its rights under the LoanAdvance Agreement to the greatest extent permitted shall in any way be deemed to waive, modify, or relax any of the rights granted Pershing or your financial organization, including those
rights vested in Pershing or your financial organization to deal with collateral on all loans advanced to you. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">Also, the LoanAdvance Agreement
constitutes the full and entire understanding between the parties with respect to the provision of the LoanAdvance Agreement, and there are no oral or other agreements in conflict with the LoanAdvance Agreement unless you have advised in writing to
Pershing or your financial organization of such conflict Any future modification amendment, or supplement to the LoanAdvance Agreement or any individual provision of the LoanAdvance Agreement can only be in writing signed by a representative of
Pershing. You should carefully review your LoanAdvance Agreement for the rights and limitations governing your LoanAdvance and collateral account relationship(s). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><I>If Article 15 of the EU Securities Financing Transactions Regulation (&#147;SFTR&#148;) is applicable to you: </I></P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">Please refer to https://www.pershing.com/_global-assets/pdf/ <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">disclosures/per-eu-article-15-info-stmt.pdf</FONT></FONT></FONT></FONT> for access to an information statement disclosing the risks and consequences of delivering <FONT
STYLE="white-space:nowrap">non-cash</FONT> collateral under a relevant collateral arrangement with Pershing LLC (including a margin account). This statement does not amend or supersede the express terms of any transaction, collateral arrangement or
otherwise affect your or our liabilities or obligations. Please contact your financial professional if you have any questions. </P></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>
 <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:SEPARATE; font-family:ARIAL; font-size:9pt">


<TR>

<TD WIDTH="53%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="border-radius:5pt 5pt 0pt 0pt ; BORDER-BOTTOM:2.00pt solid #636466 ; border-left:1pt solid #636466 ;" BGCOLOR="#636466"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt"><FONT
 COLOR="#FFFFFF"><B>&#8194;LOANADVANCE&nbsp;LENDING&nbsp;AGREEMENT&nbsp;ACKNOWLEDGEMENT</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #636466">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:2.00pt solid #636466"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">BY SIGNING THIS ACKNOWLEDGEMENT FORM, I ACCEPT THE TERMS OF THE AGREEMENT, AND: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:8.5pt">Acknowledge that I have read and understood the LoanAdvance Disclosure Statement, attached hereto, which details the
risks associated with a LoanAdvance account, and have read and understood the credit terms explained in the LoanAdvance Interest Rate Form. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:8.5pt">Acknowledge that any loan from the LoanAdvance account will not be deposited into any brokerage account.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:8.5pt">Acknowledge that any loan from the LoanAdvance account will not be used for the purpose of: (1)&nbsp;purchasing or
trading securities; (2)&nbsp;to meet margin calls relating to securities purchases; or (3)&nbsp;for reducing or retiring indebtedness incurred to purchase, carry, or trade securities. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:8.5pt">Acknowledge that Pershing may require a new T4 when the loan is increased, additional collateral accounts are added or
when other changes are requested. </P></TD></TR></TABLE></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:8.5pt">Acknowledge that the initial interest rate being assessed on the undersigned&#146;s credit line balance and the method
of computation of interest have been disclosed to me in writing. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:8.5pt">Acknowledge receipt of the LoanAdvance Interest Rate Form, which explains the annual rate of interest that can be
charged to my account, how debit balances are determined, and the methods of computing interest. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:8.5pt">Acknowledge that Pershing may compensate my Introducing Firm for its role in the establishment and maintenance of this
account. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:8.5pt"><B>ACKNOWLEDGE THAT SECURITIES HELD IN YOUR BROKERAGE OR MANAGED ACCOUNT(S) BEING USED AS COLLATERAL MAY BE LOANED TO
PERSHING OR LOANED OUT TO OTHERS. </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:8.5pt"><B>Acknowledge receiving a copy of the LoanAdvance Lending Agreement which contains a predispute arbitration clause in
paragraphs 34 and 35 above. </B></P></TD></TR></TABLE></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:1%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">
</P></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="93%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">

<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL" ALIGN="justify">&copy;&nbsp;2021 Pershing LLC. Pershing LLC, member FINRA, NYSE, SIPC, is a wholly owned subsidiary of</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:ARIAL" ALIGN="justify">The Bank of New York Mellon Corporation (BNY Mellon). Trademark(s) belong to their respective owners.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">PAGE 5 OF 6</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="right">ECAGR-LA-08-21</P></TD></TR></TABLE> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center">FORM GENERATED
ON:04/05/2024 - 11:15AM EDT </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3%; font-size:15pt; font-family:ARIAL"><FONT COLOR="#636466">LoanAdvance<SUP STYLE="font-size:75%; vertical-align:top">TM</SUP> Lending
Agreement </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #636466">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<DIV STYLE="position:relative;float:left; width:0%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:93%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:SEPARATE; font-family:ARIAL; font-size:9pt">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="69%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="border-radius:5pt 5pt 0pt 0pt ; BORDER-BOTTOM:2.00pt solid #636466 ; border-left:1pt solid #636466 ;" BGCOLOR="#636466"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt"><FONT
 COLOR="#FFFFFF"><B>STEP&nbsp;1.&nbsp;ACCOUNT&nbsp;INFORMATION</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:2.00pt solid #636466"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #636466; padding-left:8pt; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:-1.00em; font-size:7pt; font-family:ARIAL" ALIGN="justify"><FONT STYLE="white-space:nowrap">&#8201;Non-Purpose</FONT> Loan Account Number</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:-1.00em; font-size:8pt; font-family:ARIAL" align="left"><FONT STYLE="white-space:nowrap">&#8201;3ZT-047968</FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:SEPARATE; font-family:ARIAL; font-size:9pt">


<TR>

<TD WIDTH="18%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="79%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="border-radius:5pt 5pt 0pt 0pt ; BORDER-BOTTOM:2.00pt solid #636466 ; border-left:1pt solid #636466 ;" BGCOLOR="#636466"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt"><FONT
 COLOR="#FFFFFF"><B>STEP&nbsp;2.&nbsp;NAICS&nbsp;CODE</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:2.00pt solid #636466"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">All new <FONT STYLE="white-space:nowrap">non-purpose</FONT> loan accounts to an entity such as a Corporate, Partnership,
<FONT STYLE="white-space:nowrap">Non-Profit</FONT> Organization or Limited Liability Corporation account requires a six digit NAICS industry code. A complete list of NAICS is available at: https://www.naics.com/naics-drilldown-table/ </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">Please visit this Federal Government website to determine the appropriate code for your entity and provide NAIC information below. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; BORDER-TOP:1px solid #636466; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">North American Industry Description</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #636466; BORDER-TOP:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #636466; BORDER-RIGHT:1px solid #636466; padding-right:2pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">North American Industry Code (six
digit)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-left:8pt"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #636466; BORDER-BOTTOM:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-right:2pt">&#8194;541714</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:SEPARATE; font-family:ARIAL; font-size:9pt">


<TR>

<TD WIDTH="18%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="79%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="border-radius:5pt 5pt 0pt 0pt ; BORDER-BOTTOM:2.00pt solid #636466 ; border-left:1pt solid #636466 ;" BGCOLOR="#636466"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt"><FONT
 COLOR="#FFFFFF"><B>STEP&nbsp;3.&nbsp;SIGNATURES</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:2.00pt solid #636466"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL">Please be sure that all account owners sign this agreement and acknowledgement form. Caution &#151; it is important that you thoroughly
read the contract before you sign it. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="29%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>Primary Account Owner</B></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; BORDER-TOP:1px solid #636466; BORDER-RIGHT:1px solid #636466; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Print
Name</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #636466; BORDER-TOP:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #636466; BORDER-RIGHT:1px solid #636466; padding-right:2pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Date</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-left:8pt">PLUS THERAPEUTICS, INC.</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #636466; BORDER-BOTTOM:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-right:2pt"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">04-05-2024</FONT></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; BORDER-TOP:1px solid #636466; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Signature</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #636466; BORDER-RIGHT:1px solid #636466; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:20pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:20pt"><FONT COLOR="#636466"><B>/s/ ANDREW
SIMS</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>Additional Account Owner</B></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; BORDER-TOP:1px solid #636466; BORDER-RIGHT:1px solid #636466; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Print
Name</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #636466; BORDER-TOP:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #636466; BORDER-RIGHT:1px solid #636466; padding-right:2pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Date</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-left:8pt">ANDREW SIMS</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #636466; BORDER-BOTTOM:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-right:2pt"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">04-05-2024</FONT></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Signature</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #636466; BORDER-RIGHT:1px solid #636466; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:20pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:20pt"><FONT COLOR="#636466"><B>/s/ ANDREW
SIMS</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>Additional Account Owner</B></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; BORDER-TOP:1px solid #636466; BORDER-RIGHT:1px solid #636466; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Print
Name</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #636466; BORDER-TOP:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #636466; BORDER-RIGHT:1px solid #636466; padding-right:2pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Date</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-left:8pt">MARC HEDRICK</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #636466; BORDER-BOTTOM:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-right:2pt"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">04-05-2024</FONT></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; BORDER-TOP:1px solid #636466; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Signature</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #636466; BORDER-RIGHT:1px solid #636466; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:20pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:20pt"><FONT COLOR="#636466"><B>/s/ MARK
HEDRICK</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>Please Complete if a Trust, Corporation, Partnership, or Other Entity</B></P>
<P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #636466; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL" ALIGN="justify">Print Name of Entity</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #636466; BORDER-TOP:1px solid #636466; BORDER-BOTTOM:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #636466; BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-right:2pt">
<P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Date</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL">Title</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; BORDER-TOP:1px solid #636466; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Signature</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #636466; BORDER-RIGHT:1px solid #636466; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:20pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-left:8pt">
<P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:20pt"><FONT COLOR="#636466"><B>X</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:1%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">
</P></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="93%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">

<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL" ALIGN="justify">&copy;&nbsp;2021 Pershing LLC. Pershing LLC, member FINRA, NYSE, SIPC, is a wholly owned subsidiary of</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:ARIAL" ALIGN="justify">The Bank of New York Mellon Corporation (BNY Mellon). Trademark(s) belong to their respective owners.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">PAGE 6 OF 6</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="right">ECAGR-LA-08-21</P></TD></TR></TABLE> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center">FORM GENERATED
ON:04/05/2024 - 11:15AM EDT </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>d840235dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="right"><B>Exhibit 10.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:3%; font-size:28pt; font-family:ARIAL"><FONT COLOR="#636466">LoanAdvance<SUP STYLE="font-size:75%; vertical-align:top">TM</SUP> Interest Rate Form </FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #636466">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P><DIV STYLE="position:relative;float:left; width:0%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:93%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="98%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" NOWRAP STYLE="BORDER-BOTTOM:2.00pt solid #636466" BGCOLOR="#636466"> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><FONT COLOR="#FFFFFF"><B>&#8194;STEP&nbsp;1.&nbsp;ACCOUNT&nbsp;INFORMATION&#8194;</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:2.00pt solid #636466"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #636466; padding-left:8pt; padding-right:2pt"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:-0.86em; font-size:7pt; font-family:ARIAL" ALIGN="justify"><FONT COLOR="#231f20"><FONT STYLE="white-space:nowrap">Non-Purpose</FONT> Loan Account Number</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Arial Narrow" ALIGN="justify">3ZT047968</P></TD></TR>
</TABLE> <P STYLE="font-size:14pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="98%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" NOWRAP STYLE="BORDER-BOTTOM:2.00pt solid #636466" BGCOLOR="#636466"> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"><FONT
 COLOR="#FFFFFF"><B>&#8194;STEP&nbsp;2.&nbsp;INTEREST&nbsp;RATE&nbsp;ACKNOWLEDGEMENT&#8194;</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:2.00pt solid #636466"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL"><FONT COLOR="#231f20">The undersigned (&#147;<U>Borrower</U>&#148;) has executed a LoanAdvance Lending Agreement (the
&#147;<U>Agreement</U>&#148;) with Pershing LLC (&#147;<U>Pershing</U>&#148;). Pursuant to which Borrower has access to a line of credit collateralized by the value of securities held in Borrower&#146;s brokerage or separately managed account
pledged by the Borrower (the &#147;<U>Account</U>&#148;). The Account is carried by Pershing as clearing broker pursuant to a clearing agreement between Pershing and your introducing firm. This Interest Rate Acknowledgement Form constitutes a
supplement to the Agreement and shall be subject to and interpreted in accordance with the terms and conditions thereof. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL"><FONT COLOR="#231f20">The rate of
interest charged on any credit extended in the Account is a floating rate based on the Base Rate* and may fluctuate over time. In addition, if your rate is based on the interest rate schedule provided by your financial organization, the rate may be
higher or lower in the future depending on the aggregate outstanding loan amount, and any such change may be made without prior notice to Borrower. All rates described herein may be changed without prior notice to Borrower. In accordance with
Paragraph 10 of the Agreement, regardless of the underlying Base Rate, interest charged in any credit extended in a LoanAdvance account may never exceed a rate equal to 3 percentage points above the Prime Rate as published in The Wall Street
Journal. </FONT></P> <P STYLE="font-size:14pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="98%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" NOWRAP STYLE="BORDER-BOTTOM:2.00pt solid #636466" BGCOLOR="#636466"> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><FONT COLOR="#FFFFFF"><B>&#8194;STEP&nbsp;3.&nbsp;INTEREST&nbsp;RATE&#8194;</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:2.00pt solid #636466"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL"><FONT COLOR="#231f20">Subject to the foregoing, the rate of interest that will be charged on any credit extended in the Account is equal
to: </FONT></P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8.5pt" ALIGN="center">


<TR>

<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" COLSPAN="3" NOWRAP><FONT COLOR="#231f20"><B>SELECT ONE</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"><FONT COLOR="#231f20"><B>BASE&nbsp;RATE*</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP ALIGN="center"><FONT COLOR="#231f20"><B><FONT STYLE="white-space:nowrap">+/-(SELECT&nbsp;ONE)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"><FONT COLOR="#231f20"><B>SPREAD</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"><FONT COLOR="#231f20"><B>TOTAL&nbsp;RATE</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt ; margin-bottom:0pt" ALIGN="justify">


<IMG SRC="g840235dsp011.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:8.5pt"><FONT COLOR="#231f20">Federal Funds Target (Upper Limit)</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial Narrow; ">5.50</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="font-size:8.5pt" COLOR="#231f20">%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="font-size:8.5pt" COLOR="#231f20">&#8194;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:8.5pt"><FONT COLOR="#231f20"><SUB STYLE="font-size:75%; vertical-align:bottom">


<IMG SRC="g840235dsp011.jpg" ALT="LOGO">
</SUB>&nbsp;Plus</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:8.5pt"><FONT COLOR="#231f20"><SUB STYLE="font-size:75%; vertical-align:bottom">


<IMG SRC="g840235dsp011a.jpg" ALT="LOGO">
</SUB>&nbsp;Minus</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial Narrow; ">1.75</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"><FONT STYLE="font-size:8.5pt" COLOR="#231f20">&#8194;=&#8194;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial Narrow; ">7.25</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-size:8.5pt" COLOR="#231f20">%</FONT></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #939598">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #939598">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #939598">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8.5pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt ; margin-bottom:0pt" ALIGN="justify">


<IMG SRC="g840235dsp011a.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:8.5pt"><FONT COLOR="#231f20">Prime</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT COLOR="#231f20">%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:8.5pt"><FONT COLOR="#231f20"><SUB STYLE="font-size:75%; vertical-align:bottom">


<IMG SRC="g840235dsp011a.jpg" ALT="LOGO">
</SUB> Plus</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:8.5pt"><FONT COLOR="#231f20"><SUB STYLE="font-size:75%; vertical-align:bottom">


<IMG SRC="g840235dsp011a.jpg" ALT="LOGO">
</SUB> Minus</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"><FONT COLOR="#231f20">=</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT COLOR="#231f20">%</FONT></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #939598">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #939598">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #939598">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8.5pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt ; margin-bottom:0pt" ALIGN="justify">


<IMG SRC="g840235dsp011a.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:8.5pt"><FONT COLOR="#231f20">Other:</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT COLOR="#231f20">%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:8.5pt"><FONT COLOR="#231f20"><SUB STYLE="font-size:75%; vertical-align:bottom">


<IMG SRC="g840235dsp011a.jpg" ALT="LOGO">
</SUB> Plus</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:8.5pt"><FONT COLOR="#231f20"><SUB STYLE="font-size:75%; vertical-align:bottom">


<IMG SRC="g840235dsp011a.jpg" ALT="LOGO">
</SUB> Minus</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"><FONT COLOR="#231f20">=</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT COLOR="#231f20">%</FONT></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #939598">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #939598">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #939598">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #939598">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="6"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8.5pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt ; margin-bottom:0pt" ALIGN="justify">


<IMG SRC="g840235dsp011a.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" NOWRAP> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:8.5pt"><FONT COLOR="#231f20">Interest Rate Schedule Provided by my Financial Organization</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL"><FONT COLOR="#231f20">*Base Rate is determined by your financial organization and may be based on Fed Funds Target, Prime Rate as
published in The Wall Street Journal or another benchmark and may fluctuate over time. </FONT></P> <P STYLE="font-size:14pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="98%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" NOWRAP STYLE="BORDER-BOTTOM:2.00pt solid #636466" BGCOLOR="#636466"> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"><FONT
 COLOR="#FFFFFF"><B>&#8194;STEP&nbsp;4.&nbsp;RESTRICTED/CONTROL&nbsp;STOCK&nbsp;DISCLOSURE&#8194;</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:2.00pt solid #636466">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="63%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8.5pt">


<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8.5pt">
<TD VALIGN="bottom"><FONT COLOR="#231f20">1.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:ARIAL"><FONT COLOR="#231f20">Is the undersigned a control person of any publicly held
organization?</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt ; margin-bottom:0pt" ALIGN="justify">


<IMG SRC="g840235dsp011a.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:ARIAL"><FONT COLOR="#231f20">Yes&#8194;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt ; margin-bottom:0pt" ALIGN="justify">


<IMG SRC="g840235dsp011.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:ARIAL"><FONT COLOR="#231f20">No</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8.5pt">
<TD VALIGN="bottom"><FONT COLOR="#231f20">2.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:ARIAL"><FONT COLOR="#231f20">Are any of the shares subject to a control provision?</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt ; margin-bottom:0pt" ALIGN="justify">


<IMG SRC="g840235dsp011a.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:ARIAL"><FONT COLOR="#231f20">Yes</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt ; margin-bottom:0pt" ALIGN="justify">


<IMG SRC="g840235dsp011.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:ARIAL"><FONT COLOR="#231f20">No</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><FONT COLOR="#231f20"><B>If you answered yes to question 2 above, please provide details below: </B></FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:16pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="21%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #939598; BORDER-TOP:1px solid #939598; BORDER-RIGHT:1px solid #939598; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #939598; BORDER-TOP:1px solid #939598; BORDER-RIGHT:1px solid #939598">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #939598; BORDER-TOP:1px solid #939598; BORDER-RIGHT:1px solid #939598">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-LEFT:1px solid #939598; BORDER-RIGHT:1px solid #939598; BORDER-BOTTOM:1px solid #939598; padding-left:8pt"><FONT COLOR="#231f20"><B>NUMBER&nbsp;OF&nbsp;SHARES&#8195;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #939598; BORDER-BOTTOM:1px solid #939598">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-RIGHT:1px solid #939598; BORDER-BOTTOM:1px solid #939598"><FONT COLOR="#231f20"><B>NAME OF COMPANY</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #939598; BORDER-BOTTOM:1px solid #939598">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-RIGHT:1px solid #939598; BORDER-BOTTOM:1px solid #939598; padding-right:2pt"><FONT COLOR="#231f20"><B>SYMBOL</B></FONT></TD></TR>


<TR STYLE="font-size:1px; font-family:ARIAL; font-size:16pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #939598; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:16pt"><FONT COLOR="#231f20">&#8195;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #939598; BORDER-TOP:1px solid #939598; BORDER-BOTTOM:1px solid #939598">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #939598; BORDER-RIGHT:1px solid #939598; BORDER-BOTTOM:1px solid #939598">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #939598; BORDER-TOP:1px solid #939598; BORDER-BOTTOM:1px solid #939598">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #939598; BORDER-RIGHT:1px solid #939598; BORDER-BOTTOM:1px solid #939598; padding-right:2pt">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; font-family:ARIAL; font-size:16pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #939598; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:16pt"><FONT COLOR="#231f20">&#8195;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #939598; BORDER-TOP:1px solid #939598; BORDER-BOTTOM:1px solid #939598">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #939598; BORDER-RIGHT:1px solid #939598; BORDER-BOTTOM:1px solid #939598">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #939598; BORDER-TOP:1px solid #939598; BORDER-BOTTOM:1px solid #939598">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #939598; BORDER-RIGHT:1px solid #939598; BORDER-BOTTOM:1px solid #939598; padding-right:2pt">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; font-family:ARIAL; font-size:16pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #939598; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:16pt"><FONT COLOR="#231f20">&#8195;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #939598; BORDER-TOP:1px solid #939598; BORDER-BOTTOM:1px solid #939598">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #939598; BORDER-RIGHT:1px solid #939598; BORDER-BOTTOM:1px solid #939598">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #939598; BORDER-TOP:1px solid #939598; BORDER-BOTTOM:1px solid #939598">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #939598; BORDER-RIGHT:1px solid #939598; BORDER-BOTTOM:1px solid #939598; padding-right:2pt">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; font-family:ARIAL; font-size:16pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #939598; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:16pt"><FONT COLOR="#231f20">&#8195;</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #939598; BORDER-TOP:1px solid #939598; BORDER-BOTTOM:1px solid #939598">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #939598; BORDER-RIGHT:1px solid #939598; BORDER-BOTTOM:1px solid #939598">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #939598; BORDER-TOP:1px solid #939598; BORDER-BOTTOM:1px solid #939598">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #939598; BORDER-RIGHT:1px solid #939598; BORDER-BOTTOM:1px solid #939598; padding-right:2pt">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g840235dsp011b.jpg" ALT="LOGO">
 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:1%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">
</P></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="93%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">

<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL" ALIGN="justify">&copy;&nbsp;2021 Pershing LLC. Pershing LLC, member FINRA, NYSE, SIPC, is a wholly owned subsidiary of</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:ARIAL" ALIGN="justify">The Bank of New York Mellon Corporation (BNY Mellon). Trademark(s) belong to their respective owners.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">PAGE 1 OF 2</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="right">FRM-LA-DIS-ACK-10-21</P></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:15pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:11pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; font-size:15pt; font-family:ARIAL"><FONT COLOR="#636466">LoanAdvance<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP> Interest Rate Form</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:ARIAL"><FONT COLOR="#636466"><FONT STYLE="white-space:nowrap">Non-Purpose</FONT> Loan Account
Number&#8195;</FONT>3ZT047968</P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #636466">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<DIV STYLE="position:relative;float:left; width:0%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:93%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:SEPARATE; font-family:ARIAL; font-size:9pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="98%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="border-radius:5pt 5pt 0pt 0pt ; BORDER-BOTTOM:2.00pt solid #636466 ; border-left:1pt solid #636466 ;" BGCOLOR="#636466"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><FONT COLOR="#FFFFFF"><B>&#8199;STEP&nbsp;5.&nbsp;SIGNATURES&#8199;</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:2.00pt solid #636466"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">By signing below, Borrower acknowledges receipt of a completed copy of this Form, as well as any tiered interest rate
schedule, if applicable. Borrower further acknowledges their understanding and acceptance of the terms disclosed herein and attests to the accuracy of the information provided. </P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="29%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:6pt ;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt"><B>Primary Account Owner</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" STYLE="BORDER-LEFT:1px solid #636466; BORDER-TOP:1px solid #636466; BORDER-RIGHT:1px solid #636466; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #636466; BORDER-TOP:1px solid #636466; BORDER-RIGHT:1px solid #636466">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; BORDER-RIGHT:1px solid #636466; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Print Name</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #636466; padding-right:2pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Date</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-LEFT:1px solid #636466; BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-left:8pt"><FONT STYLE="font-size:10pt">ANDREW SIMS</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #636466; BORDER-BOTTOM:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-right:2pt"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">05-24-2024</FONT></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" STYLE="BORDER-LEFT:1px solid #636466; BORDER-TOP:1px solid #636466; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-TOP:1px solid #636466; BORDER-RIGHT:1px solid #636466">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Signature</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #636466; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:20pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:20pt"><FONT COLOR="#636466"><B>/s/ ANDREW
SIMS</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:6pt ;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt"><B>Additional Account Owner</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" STYLE="BORDER-LEFT:1px solid #636466; BORDER-TOP:1px solid #636466; BORDER-RIGHT:1px solid #636466; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #636466; BORDER-TOP:1px solid #636466; BORDER-RIGHT:1px solid #636466">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; BORDER-RIGHT:1px solid #636466; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Print Name</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #636466; padding-right:2pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Date</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-LEFT:1px solid #636466; BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-left:8pt"><FONT STYLE="font-size:10pt">MARC HEDRICK</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #636466; BORDER-BOTTOM:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-right:2pt"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">05-24-2024</FONT></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" STYLE="BORDER-LEFT:1px solid #636466; BORDER-TOP:1px solid #636466; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-TOP:1px solid #636466; BORDER-RIGHT:1px solid #636466">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Signature</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #636466; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:20pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:20pt"><FONT COLOR="#636466"><B>/s/ MARC
HEDRICK</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:6pt ;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt"><B>Additional Account Owner</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" STYLE="BORDER-LEFT:1px solid #636466; BORDER-TOP:1px solid #636466; BORDER-RIGHT:1px solid #636466; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #636466; BORDER-TOP:1px solid #636466; BORDER-RIGHT:1px solid #636466">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; BORDER-RIGHT:1px solid #636466; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Print Name</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #636466; padding-right:2pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Date</P></TD></TR>
<TR STYLE="font-size:1px; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-LEFT:1px solid #636466; BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-left:8pt"><FONT STYLE="font-size:10pt">&#8195;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #636466; BORDER-BOTTOM:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-right:2pt"><FONT STYLE="font-size:9pt">&#8195;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" STYLE="BORDER-LEFT:1px solid #636466; BORDER-TOP:1px solid #636466; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-TOP:1px solid #636466; BORDER-RIGHT:1px solid #636466">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Signature</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #636466; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:20pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-left:8pt">
<P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:20pt"><FONT COLOR="#636466"><B>X</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:6pt ;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt"><B>Please Complete if a Trust, Corporation, Partnership, or Other Entity</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" STYLE="BORDER-LEFT:1px solid #636466; BORDER-TOP:1px solid #636466; BORDER-RIGHT:1px solid #636466; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-TOP:1px solid #636466; BORDER-RIGHT:1px solid #636466">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-LEFT:1px solid #636466; BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-left:8pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL" ALIGN="justify">Print Name of Entity</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">PLUS THERAPEUTICS INC</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL" ALIGN="justify">Date</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:ARIAL" ALIGN="justify"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">05-24-2024</FONT></FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" STYLE="BORDER-LEFT:1px solid #636466; BORDER-RIGHT:1px solid #636466; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #636466; BORDER-RIGHT:1px solid #636466">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-LEFT:1px solid #636466; BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL">Title</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:ARIAL">CFO</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #636466; BORDER-BOTTOM:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" STYLE="BORDER-LEFT:1px solid #636466; BORDER-TOP:1px solid #636466; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-TOP:1px solid #636466; BORDER-RIGHT:1px solid #636466">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Signature</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #636466; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:20pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:20pt"><FONT COLOR="#636466"><B>/s/ ANDREW
SIMS</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:SEPARATE; font-family:ARIAL; font-size:9pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="98%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="border-radius:5pt 5pt 0pt 0pt ; BORDER-BOTTOM:2.00pt solid #636466 ; border-left:1pt solid #636466 ;" BGCOLOR="#636466"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><FONT COLOR="#FFFFFF"><B><FONT STYLE="white-space:nowrap">&#8199;FOR&nbsp;BROKER-DEALER&nbsp;USE&nbsp;ONLY&#8199;</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:2.00pt solid #636466"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL">The information below must be submitted for all LoanAdvance accounts, regardless of which interest rate index is selected. In addition,
by signing below, the Branch Manager acknowledges that they have provided the Borrower with the Broker-Dealers tiered interest rate schedule, if applicable. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="29%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; BORDER-TOP:1px solid #636466; BORDER-RIGHT:1px solid #636466; padding-left:8pt"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:ARIAL" ALIGN="justify">Print Branch Manager Name</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #636466; BORDER-TOP:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #636466; BORDER-RIGHT:1px solid #636466; padding-right:2pt"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:ARIAL" ALIGN="justify">Date</P></TD></TR>
<TR STYLE="font-size:1px; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-left:8pt"><FONT STYLE="font-size:10pt">&#8195;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #636466; BORDER-BOTTOM:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-right:2pt"><FONT STYLE="font-size:9pt">&#8195;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" STYLE="BORDER-LEFT:1px solid #636466; BORDER-TOP:1px solid #636466; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-TOP:1px solid #636466; BORDER-RIGHT:1px solid #636466">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Signature</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #636466; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:20pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-left:8pt">
<P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:20pt"><FONT COLOR="#636466"><B>X</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #636466; BORDER-BOTTOM:1px solid #636466; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:1%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">
</P></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="93%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">

<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL" ALIGN="justify">&copy;&nbsp;2021 Pershing LLC. Pershing LLC, member FINRA, NYSE, SIPC, is a wholly owned subsidiary of</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:ARIAL" ALIGN="justify">The Bank of New York Mellon Corporation (BNY Mellon). Trademark(s) belong to their respective owners.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">PAGE 2 OF 2</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="right">FRM-LA-DIS-ACK-10-21</P></TD></TR></TABLE>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>d840235dex103.htm
<DESCRIPTION>EX-10.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="right"><B>Exhibit 10.3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:3%; font-size:28pt; font-family:ARIAL"><FONT COLOR="#636466">Statement&nbsp;of&nbsp;Purpose&nbsp;for&nbsp;an&nbsp;Extension </FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3%; font-size:28pt; font-family:ARIAL"><FONT COLOR="#636466">of&nbsp;Credit&nbsp;by&nbsp;a&nbsp;Creditor&nbsp;
</FONT><FONT STYLE="font-family:ARIAL; font-size:20pt" COLOR="#636466">(Federal&nbsp;Reserve&nbsp;Form&nbsp;T&#150;4)</FONT><FONT STYLE="font-family:ARIAL; font-size:28pt" COLOR="#636466"> </FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #636466">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<DIV STYLE="position:relative;float:left; width:0%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:93%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>Name of Creditor: Pershing LLC &#149; OMB No.&nbsp;7100-0019 &#149; Approval expires June&nbsp;30, 2024
</B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL">This form is required by law (15 U.S.C. 78g and 78w; 12 CFR 220). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL">The Federal Reserve may not conduct or sponsor, and an organization (or a person) is not required to respond to, a collection of information unless it displays a
currently valid OMB control number. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL">Public reporting burden for this collection of information is estimated to average 10 minutes per response, including the time
to gather and maintain data in the required form and to review instructions and complete the information collection. </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL">Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions
for reducing this burden to Secretary, Board of Governors of the Federal Reserve System, 20th and C Streets, N.W., Washington, DC 20551; and to the Office of Management and Budget, Paperwork Reduction Project (7100-0019), Washington, DC 20503.
</P></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>
 <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #636466">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>Instructions </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">This form must be completed only
if the purpose of the credit being extended is not to purchase, carry, or trade in securities and the credit is in excess of that otherwise permitted under Regulation T. (See &#167; 220.6(e)(2)). If space is inadequate, attach separate sheet. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="98%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" NOWRAP STYLE="BORDER-BOTTOM:2.00pt solid #636466" BGCOLOR="#636466"> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><FONT COLOR="#FFFFFF"><B>&#8194;PART&nbsp;I&nbsp;&#8194;</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #636466">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:2.00pt solid #636466"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>Step 1. Account&nbsp;Information </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #636466; padding-left:8pt; padding-right:2pt"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:-0.86em; font-size:7pt; font-family:ARIAL" ALIGN="justify"><FONT COLOR="#231f20"><FONT STYLE="white-space:nowrap">Non-Purpose</FONT> Loan Account Number</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Arial Narrow" ALIGN="justify">3ZT047968</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8.5pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="84%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-size:9pt"><B>Step 2. To be Completed by the Customer(s)</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8.5pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:8.5pt; font-family:ARIAL">


<IMG SRC="g840235dsp011a.jpg" ALT="LOGO">
&#8194;&#8201;&#8202;<B>New loan. </B>Amount of the credit being requested $
<U>&#8195;&#8194;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8201;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8.5pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:8.5pt; font-family:ARIAL">


<IMG SRC="g840235dsp011a.jpg" ALT="LOGO">
&#8194;&#8201;&#8202;<B><FONT STYLE="white-space:nowrap">Non-purpose</FONT> loan transfer </B>(if applicable)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8.5pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:8.5pt; font-family:ARIAL">


<IMG SRC="g840235dsp011a.jpg" ALT="LOGO">
&#8194;&#8201;&#8202;Pershing delivering <FONT STYLE="white-space:nowrap">non-purpose</FONT> loan account
<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8194;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8.5pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:8.5pt; font-family:ARIAL">


<IMG SRC="g840235dsp011a.jpg" ALT="LOGO">
&#8194;&#8201;&#8202;External delivering firm name
<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8.5pt">
<TD VALIGN="bottom" COLSPAN="3"><FONT COLOR="#231f20"><SUB STYLE="font-size:75%; vertical-align:bottom">


<IMG SRC="g840235dsp011.jpg" ALT="LOGO">
</SUB>&nbsp;<B>Credit line increase. </B>New credit line amount
$<U>&#8194;<FONT STYLE="font-size:10pt" COLOR="#231f20">3,300,000.00</FONT><FONT COLOR="#231f20">&#8194;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8201;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8194;&#8195;&#8195;
</FONT></U></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8.5pt">
<TD VALIGN="bottom"><B>Purpose&nbsp;of&nbsp;credit</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8.5pt">
<TD VALIGN="bottom" COLSPAN="3">The purpose of the credit is described in details as follows</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="10"></TD>
<TD HEIGHT="10" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8.5pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:8.5pt; font-family:ARIAL">


<IMG SRC="g840235dsp011.jpg" ALT="LOGO">
&#8194;&#8201;&#8202;Liquidity/Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:8.5pt; font-family:ARIAL">


<IMG SRC="g840235dsp011a.jpg" ALT="LOGO">
&#8194;&#8201;&#8202;Other
<U>&#8195;&#8195;&#8195;&#8194;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8194;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>Delivery </B></P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">Are
any of the securities listed in Part II to be delivered, or have any such securities been delivered from a bank, broker, dealer, or other person on a &#147;delivery against payment&#148; basis? </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify"><FONT COLOR="#231f20"><SUB STYLE="font-size:75%; vertical-align:bottom">


<IMG SRC="g840235dsp011a.jpg" ALT="LOGO">
</SUB>&#8194;Yes&#8194;


<IMG SRC="g840235dsp011.jpg" ALT="LOGO">
&#8201;No </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g840235dsp0013.jpg" ALT="LOGO">
 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:1%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">
</P></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="93%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">

<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL" ALIGN="justify">&copy;&nbsp;2021 Pershing LLC. Pershing LLC, member FINRA, NYSE, SIPC, is a wholly owned subsidiary of</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:ARIAL" ALIGN="justify">The Bank of New York Mellon Corporation (BNY Mellon). Trademark(s) belong to their respective owners.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right">PAGE 1 OF 3</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">FRM-LA-T4-08-21</FONT></FONT></FONT></FONT></P></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:15pt" ALIGN="center">


<TR>

<TD WIDTH="55%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:11pt">
<TD VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.00pt solid #939598">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; font-size:15pt; font-family:ARIAL"><FONT COLOR="#636466">Statement&nbsp;of&nbsp;Purpose&nbsp;for&nbsp;an&nbsp;Extension&nbsp;of</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; font-size:15pt; font-family:ARIAL"><FONT COLOR="#636466">Credit&nbsp;by&nbsp;a&nbsp;Creditor&nbsp;</FONT><FONT STYLE="font-size:12pt" COLOR="#636466">(Federal&nbsp;Reserve&nbsp;
Form&nbsp;T&#150;4)</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #939598">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.00pt solid #939598"><FONT STYLE="white-space:nowrap">Non-Purpose&nbsp;Loan&nbsp;Account&nbsp;Number</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #939598">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.00pt solid #939598">3ZT047968</TD></TR>
</TABLE> <P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>Step 3. Signature(s) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">I (We) have read this form and certify that to the best of my (our) knowledge and belief the information given is true, accurate, and complete. Unless
otherwise noted in the respective section on page two, the collateral supporting the extension of credit is maintained in the brokerage account referenced above. The borrower acknowledges that no part of this credit will be used to purchase, carry,
or trade in securities. </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="justify">This form should not be signed if blank. A borrower who falsely certifies the purpose of a credit on this form or otherwise
willfully or intentionally evades the provisions of Regulation T will also violate Federal Reserve Regulation X, &#147;Borrowers of Securities Credit.&#148; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="26%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #939598"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>Primary Account Owner</B></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #939598">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #939598"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #939598; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Print Name</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #939598">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #939598; padding-right:2pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Date</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #939598; BORDER-BOTTOM:1px solid #939598; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">&#8199;ANDREW SIMS</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #939598; BORDER-BOTTOM:1px solid #939598">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #939598; BORDER-BOTTOM:1px solid #939598; padding-right:2pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">05-29-2024</FONT></FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #939598; BORDER-BOTTOM:1px solid #939598; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL" ALIGN="justify">Signature</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:20pt; font-family:ARIAL" ALIGN="justify"><FONT COLOR="#636466"><B>/s/ Andrew Sims</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #939598">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #939598; BORDER-BOTTOM:1px solid #939598; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #939598"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>Additional Account Owner</B></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #939598">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #939598"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #939598; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Print Name</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #939598">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #939598; padding-right:2pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Date</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #939598; BORDER-BOTTOM:1px solid #939598; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">MARC HEDRICK</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #939598; BORDER-BOTTOM:1px solid #939598">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #939598; BORDER-BOTTOM:1px solid #939598; padding-right:2pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">05-29-2024</FONT></FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #939598; BORDER-BOTTOM:1px solid #939598; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL" ALIGN="justify">Signature</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:20pt; font-family:ARIAL" ALIGN="justify"><FONT COLOR="#636466"><B>/s/ Marc Hedrick</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #939598">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #939598; BORDER-BOTTOM:1px solid #939598; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #939598"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>Additional Account Owner</B></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #939598">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #939598"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #939598; BORDER-BOTTOM:1px solid #939598; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL" ALIGN="justify">Print Name</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #939598; BORDER-BOTTOM:1px solid #939598">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #939598; BORDER-BOTTOM:1px solid #939598; padding-right:2pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Date</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #939598; BORDER-BOTTOM:1px solid #939598; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL" ALIGN="justify">Signature</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:20pt; font-family:ARIAL" ALIGN="justify"><FONT COLOR="#636466">X</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #939598">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #939598; BORDER-BOTTOM:1px solid #939598; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #939598"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="justify"><B>Please Complete if a Trust, Corporation, Partnership, or Other Entity</B></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #939598">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #939598"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #939598; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Print Name of Entity</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #939598">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #939598; padding-right:2pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Date</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #939598; BORDER-BOTTOM:1px solid #939598; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">PLUS THERAPEUTICS INC</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #939598; BORDER-BOTTOM:1px solid #939598">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #939598; BORDER-BOTTOM:1px solid #939598; padding-right:2pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">05-29-2024</FONT></FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #939598; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">Title</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #939598">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #939598; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #939598; BORDER-BOTTOM:1px solid #939598; padding-left:8pt"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">CFO</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #939598; BORDER-BOTTOM:1px solid #939598">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #939598; BORDER-BOTTOM:1px solid #939598; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #939598; BORDER-BOTTOM:1px solid #939598; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL" ALIGN="justify">Signature</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:20pt; font-family:ARIAL" ALIGN="justify"><FONT COLOR="#636466"><B>/s/ Andrew Sims</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #939598">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #939598; BORDER-BOTTOM:1px solid #939598; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">&copy;&nbsp;2021 Pershing LLC. Pershing LLC, member FINRA, NYSE, SIPC, is a wholly owned subsidiary of</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">PAGE 2 OF 3</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:7pt">The Bank of New York Mellon Corporation (BNY Mellon). Trademark(s) belong to their respective owners.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">FRM-LA-T4-08-21</FONT></FONT></FONT></FONT></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>pstv-20240531.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 6/5/2024 12:39:15 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2023"
  xmlns:pstv="http://www.plustherapeutics.com/20240531"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.plustherapeutics.com/20240531"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" namespace="http://xbrl.sec.gov/naics/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pstv-20240531_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pstv-20240531_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.plustherapeutics.com//20240531/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>pstv-20240531_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 6/5/2024 12:39:15 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>pstv-20240531_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 6/5/2024 12:39:15 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.plustherapeutics.com//20240531/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="pstv-20240531.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.plustherapeutics.com//20240531/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g840235dsp0013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g840235dsp0013.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MI'[S&,1-GGN/P -BS^*^A7O@34/%\5I?C3["<021M&GFEB4&0-^,?O%[CH:
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M0RKCY7)SEAVH C^*/_,E_P#8S67_ +/0!\Q^.O\ DH/B7_L)W/\ Z-:@1O\
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M_P#^P9)_Z-BH!'KWQ1_YDO\ [&:R_P#9Z!GS'XZ_Y*#XE_["=S_Z-:@1O_\
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,]3O*D H * "@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g840235dsp011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g840235dsp011.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /TA^)_[3'A[X>_'?P;\'/$7BSQMI.K_ !/\9'PYX670=/\
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LG[.GS2E*7/4J3UJ5:CMS5*DK).322T2C&*C"$8PC&*^DZY#I"@ H * /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g840235dsp011a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g840235dsp011a.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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7P"TK=E9/JNP?A:W0]6J1A0 4 % '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g840235dsp011b.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g840235dsp011b.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M+_\ M8_^NS_C)0 ?&3_E(1^R=_V7_P 1_P#KS#]I:@#Y_P#^<IO_ '?_ /\
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M (I_]5U\*J /H#]HW_F_K_LP#P;_ ._J4 ?@#^SC_P V"_\ 9_\ XR_]\KH
M\ _:6_Y*+X<_[(!^R=_ZRQ\&Z /U^_X**_\ )]FB?]F ?M#_ /JG?VN: /@#
M_@G5_P EBUO_ +MX_P#6Z_V1J /H#]FG_E'OXC_[+_\ M8_^NS_C)0 ?&3_E
M(1^R=_V7_P 1_P#KS#]I:@#Y_P#^<IO_ '?_ /\ OQ5 !^SC_P V"_\ 9_\
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MNXTYSIXFI%7AA*%;$U7=+DH8>G*K5G9N\N2$7+EBI3E:T8R=D>?_ +/WPO\
MV91X,US]A_PC^UO9^*/B8WQ1^.WB.5[KX+^,_";C5/%7[-GCO]F_6O#=E!KV
MK1Z9JMWHC>(;OQ$)+37)&OTT:6SA@CCD;4(%@HRS#!SQV"7M\+3P\,5*2]V2
MP\^3EJ^SERU'%<\.:T&X*2<U%&>*:P-;ZOBOW-55GAVMTJR;CR.<.:$;RCR1
MDY*,IN,(R<IQ3L6/PF_9K^/O[7_@7Q7X'_:UL9O'7P)\?^+/'6K?#.Y^#GB[
M3+O6CIG[3WQ2_:#UO2-/\1>(=:TNWGDL&\=SZ#)-IMKJK-'H3:JL'E77V2VQ
MHUJ=?*ZV<T9<^78;#0Q=2JD[PPTXJ4:SI->VY+2BI-4WR2G3A/EG4A&5UHO#
M9A1RNLO9XVO7EAJ=-_#+$0?*Z/M5>BIW4G&+J+GC&<H<T83<?./@U^SG^S5^
MT%^VG=_%[X0_MA?\)=XIL/C/=_M)77PV_P"&??'V@>3I-A\4++QC=:#_ ,)C
MXGUS3K1]EUJ-GIOVU+)I6\[[2M@51HE[*6$Q%;"8C'4J?-A<+*C"K/FBN66(
M]I[)<K:G+F]E4UC%J/+[SC=7RK3CAJU/#U7R5JDYTXQLW>=.,IR5XWBK1A)W
M;2=K)MM)_47PX_X)2?\ "O\ _A07_%^O[6_X4=\?]9^.?_)+OL'_  D_]K?\
M*5_XI;_DHMS_ &)Y7_"G_P#D)?Z?O_X2+_CS7[!_IO/L7L?7_A3]E+_A&?BG
MI7Q+_P"$]^V_V9\0-?\ '7]B?\(M]F\[^W/$7[:NO_V7_:7_  D4OE>1_P -
M@^1]I^RMO_X5WYGDI_;VS13;Y!M\CY _:*_X)2?\+]\8V/BS_A?7_")_8_\
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5MMZRDWOI>RLK(W*YS0* "@ H __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140153964768896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001095981<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 31,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PLUS THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-34375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-0827593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4200 Marathon Blvd.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Austin<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">78756<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(737)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">255-7194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PSTV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>14
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M='@//GL?)=-[*CG_5U/\!%!+ P04    "   BL18EXJ[',     3 @  "P
M %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=
MOZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'
MTD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[P
MS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T
M>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    (  "*Q%@<.&7J/P$
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M?P%02P$"% ,4    "   BL18!T%-8H$   "Q    $               @ $
M    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (  "*Q%BC4EZ#[P   "L"
M   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0
M   (  "*Q%B97)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M
M92]T:&5M93$N>&UL4$L! A0#%     @  (K$6$FH:\1H!   +Q$  !@
M         ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0
M   (  "*Q%B?H!OPL0(  .(,   -              "  :P,  !X;"]S='EL
M97,N>&UL4$L! A0#%     @  (K$6)>*NQS     $P(   L
M ( !B \  %]R96QS+RYR96QS4$L! A0#%     @  (K$6!PX9>H_ 0  / (
M  \              ( !<1   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M  "*Q%@D'INBK0   /@!   :              "  =T1  !X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (  "*Q%AED'F2&0$  ,\#   3
M              "  <(2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )
-  D /@(   P4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.1.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d840235d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.plustherapeutics.com//20240531/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:SecurityExchangeName -  d840235d8k.htm 7</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d840235d8k.htm">d840235d8k.htm</File>
    <File>pstv-20240531.xsd</File>
    <File>pstv-20240531_lab.xml</File>
    <File>pstv-20240531_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>21
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d840235d8k.htm": {
   "nsprefix": "pstv",
   "nsuri": "http://www.plustherapeutics.com/20240531",
   "dts": {
    "inline": {
     "local": [
      "d840235d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "pstv-20240531.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "pstv-20240531_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "pstv-20240531_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://www.plustherapeutics.com//20240531/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-05-31_to_2024-05-31",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d840235d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-05-31_to_2024-05-31",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d840235d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.plustherapeutics.com//20240531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.plustherapeutics.com//20240531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.plustherapeutics.com//20240531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.plustherapeutics.com//20240531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.plustherapeutics.com//20240531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.plustherapeutics.com//20240531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.plustherapeutics.com//20240531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.plustherapeutics.com//20240531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.plustherapeutics.com//20240531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.plustherapeutics.com//20240531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.plustherapeutics.com//20240531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.plustherapeutics.com//20240531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.plustherapeutics.com//20240531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.plustherapeutics.com//20240531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.plustherapeutics.com//20240531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.plustherapeutics.com//20240531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.plustherapeutics.com//20240531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.plustherapeutics.com//20240531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.plustherapeutics.com//20240531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.plustherapeutics.com//20240531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.plustherapeutics.com//20240531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.plustherapeutics.com//20240531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.plustherapeutics.com//20240531/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>22
<FILENAME>0001193125-24-154380-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-154380-xbrl.zip
M4$L#!!0    (  "*Q%@G?"G@N!,  "EZ   .    9#@T,#(S-60X:RYH=&WM
M/6MSXKBRW_,K5,R9W:0J/&Q@$DB&4QG"['(VD^0&YN[>^V5+V"+HC+&]DIS
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M-7,46^>,>5BD9 DB<-7IZU.T#S%O]]%$&72K7KMRF0A:5@PC&B@2XS"FT7
M92U8*?@P*VHZ@TBINBD(VPSR3JHTU\"]*MN9>6+@P(R44QC]C &4343&Y-07
M#B%^D^W-;;WW$^_*^1+%7T7!.,(4F2:<!\=&'MY$+=9L/3];"ZY6.KVW"Z=9
M&5M_V71.W6O-L#JV0',V(V@\D"O /T>^-G8!WO:C1&C:/B&HXJ\K% H&E185
M0#?]!Q";B()L+%9\YVJG<^Q, Y<8[FC?)#V<NP%#2:4L%UVQ6"[X7VV?UW8^
MRTZ;$7>Q_2TP!*F5VAJ+MK.-V+'BA21OD/A',H"UC!R=KN3Z@26TL08?B3AU
M-8D$?^EON' :1>O/>4GL?><PO:C<0[TV=;^:$TX,E; /D*U1-H19]T"H#8'#
M<Q.B^CB)(<$7O^']2>PF830;9J!F9!KKVF J&T9LXL#T!5,(CFL>SN UL$YT
M229M6U,U_K,IIEX#P;,,,22Z17'H71OEU_/$?";&4::C[K5[KH@GEI/3?@Q$
MZ*=LD"C?R<H(Q2LB%"2_LMI>KUGJX$IMJW<2;<+H"F<,H'?')$*PFMK0PE5#
M[*15.JA6-RR+B>";LO;=#"^*1<_XM$8 2O/GY'J&-0Z9)]#TL9?[QEZ".,W
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M>U <AQG92'U=R?Q B4-()PC8\K )6:&'4&+L8Z=>HT5!XP5></0FT8[S2$5
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MR&TFZ>X\BF-TCO^_R?^3B/YYXCR5]Z+XF5P^;2L?(H[,5S]Q9S.DZ G7X42
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M[;Z5I>%N[T[&93\<HKRG%-@MNP46^AOL,KT<^EIJ/&B"(<1AG$X(3M4E(P8
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MQD;T#PCDRN%2N$&Z,1H[T="]O9E.3*N3*8TZ4=6!1WA$W(Y;;^697/B$//P
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MX5"GT!'&%J;XH4@7K ^I(N&MRD"Y#F2%(*WD#'K;)LK /],)*OI74JZ(<!\
M@\[+&(-J@^9AV(M''(D*[;8&(RO7ZGRTY*AV2AK9PED9.1S-IC2)&J^*?,SK
M>$7DG@%N/HZQ$G)7"^NBIEA(J-0AE4=; 8G;KW'UHT73;J!.A:^_,^%N&\^X
M]27XDZ2.$#6WS@T'7> T""&1F2M#)NU,90N-EI&T[1;CL<A%3,1<%?M-\'6R
M4*_A2Y\U7/]8(='I@Y%Z6_Q@J/NCD1I9W&<C12'(*D%>"NG12(LV#,]&;+V4
M=URK+?V5*_DNFGWQB-KS/U!+ P04    "   BL18.HBYJ,T$  !/+   %0
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MLXK'3TZ$J"^Z%VU;D/_#YLAU<)2:@2XP!V&W5\P_<ZQ3E_P#4$L! A0#%
M  @  (K$6"=\*>"X$P  *7H   X              ( !     &0X-# R,S5D
M.&LN:'1M4$L! A0#%     @  (K$6*)%H3 5/P  +7H! !$
M ( !Y!,  &0X-# R,S5D97@Q,#$N:'1M4$L! A0#%     @  (K$6/W!ZX\4
M$@  CM4  !$              ( !*%,  &0X-# R,S5D97@Q,#(N:'1M4$L!
M A0#%     @  (K$6.$Z$#'A#@  9W(  !$              ( !:V4  &0X
M-# R,S5D97@Q,#,N:'1M4$L! A0#%     @  (K$6(R\IGU$ P  9 L  !$
M             ( !>W0  '!S='8M,C R-# U,S$N>'-D4$L! A0#%     @
M (K$6$,[%JM_!@  N48  !4              ( ![G<  '!S='8M,C R-# U
M,S%?;&%B+GAM;%!+ 0(4 Q0    (  "*Q%@ZB+FHS00  $\L   5
M      "  :!^  !P<W1V+3(P,C0P-3,Q7W!R92YX;6Q02P4&      < !P"^
) 0  H(,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>d840235d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="pstv-20240531.xsd" xlink:type="simple"/>
    <context id="duration_2024-05-31_to_2024-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001095981</identifier>
        </entity>
        <period>
            <startDate>2024-05-31</startDate>
            <endDate>2024-05-31</endDate>
        </period>
    </context>
    <dei:SecurityExchangeName
      contextRef="duration_2024-05-31_to_2024-05-31"
      id="Hidden_dei_SecurityExchangeName">NASDAQ</dei:SecurityExchangeName>
    <dei:AmendmentFlag contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-292">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-05-31_to_2024-05-31"
      id="Hidden_dei_EntityCentralIndexKey">0001095981</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-303">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-304">2024-05-31</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-305">PLUS THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-306">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-307">001-34375</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-308">33-0827593</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-309">4200 Marathon Blvd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-310">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-311">Austin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-312">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-313">78756</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-314">(737)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-315">255-7194</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-316">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-317">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-318">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-319">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-320">Common Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-321">PSTV</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-05-31_to_2024-05-31" id="ixv-322">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
